Keynote: Josh Palmer, GSK

• 

  Josh Palmer

  Josh is the Global Real Estate transaction lead for GSK, focusing on aligning real estate strategies with business objectives and transforming the portfolio to create the World’s healthiest workplaces.

  GSK

  Senior Director, Global Real Estate Lead

  Keynote

  Josh Palmer

  Senior Director, Global Real Estate Lead

  GSK

• 

  Mike Phillips

  Mike is UK editor of Bisnow. Before this, alongside three friends he bought pan-European property mag EuroProperty out of non-existence and re established it before selling the business to PropertyEU. Prior to that he was editor of Property Week, and has also worked for Estates Gazette.

  Bisnow

  UK Editor

  Moderator

  Mike Phillips

  UK Editor

  Bisnow

Follow the Money: Our Investment and Finance Outlook

Understand what drives investor interest and why new players are entering the sector

• 

  David Marks

  David Marks is the CEO and co-founder of Brockton Everlast, a London- based real estate investment firm established in 2006. The firm has raised over £2.20 billion in institutional capital, developing and investing into 370 properties across 22m sq ft. Its current focus spans three areas: a 2m sq ft masterplan of laboratories in Cambridge, 1m sq ft of office development in central London, and Fora, London’s largest flex office operator, managing 3m sq ft and 30,000 desks across 70 buildings in partnership with Blackstone. David has been a member of the Bank of England’s Commercial Property Forum since 2006 and a trustee of the National Gallery since 2017. David holds a Master’s from MIT and a BA from the University of Manchester.

  Brockton Everlast

  Chief Executive Officer and Co-Founder

  David Marks

  Chief Executive Officer and Co-Founder

  Brockton Everlast

• 

  Will Hawking

  Will has over 17 years industry experience in commercial real estate and has spent the past 5 years leading the evolution of the Life Science investment and asset management strategy at Royal London across the mandated funds. During this time RLAM have established a life science portfolio in excess of 1.5 million sq ft principally focussed across the Uk Golden Triangle.

  Royal London Asset Management

  Head of Life Sciences

  Will Hawking

  Head of Life Sciences

  Royal London Asset Management

• 

  Jackie Sadek

  Jackie Sadek has 40 years’ experience in property, specializing in public-private sector partnerships. A former Specialist Adviser to Government on urban regeneration, Jackie now runs Urban Strategy, an urban regeneration consultancy. She was part of the Grimsey Review team on the future of the high street and is an honorary Fellow of the Association of Chief Estates Surveyors. She is co-author (with Peter Bill) of “Broken Homes”. Jackie is chair of the EG Public Sector Forum. She is also chair of the UK Innovation Corridor, a bottom-up partnership of 15+ local authorities, six universities and hundreds of innovation and science companies in the London-Stansted-Cambridge sub region.

  Urban Strategy

  Director

  Jackie Sadek

  Director

  Urban Strategy

• 

  Peter Langly-Smith

  Peter Langly-Smith is Managing Director of Reef + Partners. Pete has 20 years' experience in development and investment management and is currently overseeing the delivery of TRIBECA, London's largest purpose built life sciences campus in King's Cross: nearly one million sq ft of mixed-use, life sciences-led space across four buildings, where The Francis Crick Institute and the London Bioscience Innovation Centre (LBIC) are collaborating with Reef within the Tribeca ecosystem.

  Reef + Partners

  Managing Director

  Peter Langly-Smith

  Managing Director

  Reef + Partners

• Moderator

  Chris Xitsas

  Partner, Commercial Real Estate

  Maples Teesdale

Embracing the Evolution: Developing the Next Wave of Innovation Districts

From incorporation of new sectors like cell therapy to quantum mechanics and continuing to attract/retain young talent, learn how today's owners and developers are rethinking what makes their life science spaces stand out

• 

  Chas Bountra

  Chas Bountra is Pro Vice-Chancellor for Innovation at the University of Oxford. He is Professor of Translational Medicine in the Nuffield Department of Clinical Medicine and Associate Member of the Department of Pharmacology at the University of Oxford. He is also a Visiting Professor in Neuroscience and Mental Health at Imperial College, London. Chas is an invited expert on several government and charitable research funding bodies, and an advisor for many academic, biotech and pharma drug discovery programmes. He trained at King’s College London and the University of Edinburgh before taking up a post-doctoral fellowship and college lectureship in Physiology at Oxford. Prior to returning to Oxford, he worked for 19 years in the pharmaceutical industry, where he was involved in the development of candidate drugs for several diseases, including novel treatments for cancer chemotherapy and IBS. In 2018, he was awarded the “Order of the British Empire” in the New Years Honours list.

  University of Oxford

  Pro Vice-Chancellor for Innovation

  Chas Bountra

  Pro Vice-Chancellor for Innovation

  University of Oxford

• 

  Peter Ward

  Peter is leading a programme for the redevelopment of the Guy’s and St Thomas’ campuses and community facilities in Lambeth and Southwark, with a combined capital value of more than £2bn over the next decade. Until November 2017 he was the Director of Healthcare Projects for John Laing, a leading international investor in economic and social infrastructure which delivered more than 20 major healthcare Public-Private Partnership projects and over 40 clinics and primary care facilities during his time there. He has worked on the development of public infrastructure since 1989 and has substantial experience in the successful structuring and delivery of a diverse range of project financing, PPP and development projects in the healthcare, water and transportation sectors in the UK and overseas. Since 2001 he has managed the development of healthcare projects with a capital value exceeding £2bn. Peter is a Chartered Civil Engineer and a Fellow of the Institution of Civil Engineers, and has served two full terms as a Non-Executive Director of the Oxford University Hospitals NHS Foundation Trust. He also led the development of a UN standard for the use of PPP in the healthcare sector for the United Nations Economic Commission for Europe, and remains a member of the United Nations PPP Business Advisory Board.

  Guy's and St Thomas'​ NHS Foundation Trust

  Director of Real Estate Development

  Peter Ward

  Director of Real Estate Development

  Guy's and St Thomas'​ NHS Foundation Trust

• 

  Artem Korolev

  Artem Korolev is the Founder and Chief Executive of Mission Street. Over a five-year period, he built the company into one of the UK’s leading specialist investors and developers in science and innovation real estate, with a committed development pipeline in excess of 1m sq ft in Cambridge, Oxford and Bristol. Korolev was previously Head of UK Acquisitions and a member of the founding team of GreenOak Real Estate (now BentallGreenOak). Korolev’s track record spans development, asset management, real estate private equity and finance. This includes property acquisitions and corporate M&A, leading end-to-end delivery of complex development and asset management projects across the UK, and structuring debt and equity financing.

  Mission Street

  Founder and CEO

  Artem Korolev

  Founder and CEO

  Mission Street

• 

  Simon Erridge

  Simon is a Director at Bennetts Associates, a renowned UK practice celebrated for its pioneering sustainability initiatives. Simon's passion derives from architecture’s potential to positively influence life in towns and cities. He works with clients in the property, science, education and culture sectors where projects include devising masterplans and designing hybrid workspaces, retrofitting listed buildings and creating vibrant all-day cultural venues. Simon continues to spearhead Bennetts Associates' innovative approach, with his recent projects which include Tribeca, a mixed-use campus for life sciences in the heart of London's Knowledge Quarter and Manchester's first net-zero carbon hotel tower. Simon has successfully led some of the practice's most notable projects, including RIBA National Award-winning schemes at Shaftesbury Theatre and the Royal College of Pathologists in London and Storyhouse in Chester, and has recently led a research project on net-zero labs prototypes.

  Bennetts Associate

  Director

  Simon Erridge

  Director

  Bennetts Associate

• 

  Martin Ray

  Martin Ray is Currie & Brown global pharmaceutical and life sciences industry lead. He has spent a significant part of his 35-year career in life sciences co-located with clients managing outsourced project delivery teams and has worked in most business areas and facility types. Projects delivered include laboratories, offices, high containment facilities, primary and secondary production, filling and packaging, support buildings and site-wide infrastructure projects. This experience enables him to understand and empathise with our client’s priorities and issues, identify and mitigate risk and quickly shape our service offering to complement clients’ requirements. Martin is based in our London office and has worked extensively in the private and public sectors in and around London, also delivering projects nationally and internationally.

  Currie & Brown

  Senior Director

  Martin Ray

  Senior Director

  Currie & Brown

• 

  Neelam Patel

  Neelam’s diverse experience includes an extensive career in the pharmaceutical industry in global leadership positions, as well as public sector experience, designing and implementing initiatives to fast-track innovation development and adoption in the UK. Neelam has led the development and implementation of national industry strategies for the NIHR and DHSC and has been an invited industry representative to deliver pan-European programmes spanning the private and public sector. Her experience is often sought by regional organisations that are looking to create or overhaul their health innovation strategies to improve health outcomes and generate economic growth. As CEO of MedCity, she championed the growth of a globally connected life sciences innovation ecosystem, convening established and new London innovation districts and working with UK clusters to promote UK Life Sciences internationally. Her current portfolio includes advisor to the newly licensed NIHR HRC (IVD) hosted at Imperial, NED on the board of the HRA, mentor to SMEs and leading regional health innovation development initiatives.

  NIHR Healthtech Research Centre

  Industry Strategy Advisor

  Moderator

  Neelam Patel

  Industry Strategy Advisor

  NIHR Healthtech Research Centre

Presentation: Allies & Morrison

• 

  Billy Choi

  Billy Choi is a Director and Head of Life Sciences at Allies and Morrison, a leading practice of architects and urban designers making architecture and places across the UK and around the world. An architect with a decade of experience in science buildings and innovation districts, Billy has been leading projects for Imperial College London, Stanhope and other clients in London and Cambridge. He also oversees Allies and Morrison’s work in life sciences, led by a keen interest in flexible, low-carbon and progressive designs, and in creating characterful and delightful workplaces for scientists.

  Allies and Morrison

  Director and Head of Life Sciences

  Billy Choi

  Director and Head of Life Sciences

  Allies and Morrison